OKYO Pharma Announces Chairman and CEO Acquire Shares
January 31, 2025 07:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic...
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
January 03, 2025 07:00 ET
|
AccuStem Sciences, Inc
LONDON and PHOENIX, Jan. 03, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced...
OKYO Pharma Announces Chairman Acquires Shares
September 10, 2024 07:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
OKYO Pharma Announces Chairman Acquires Shares
September 05, 2024 07:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
OKYO Pharma Announces Chairman Acquires Shares
August 23, 2024 07:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
OKYO Pharma Announces Chairman Acquires Shares
August 21, 2024 07:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Stryve Foods Appoints Former Frito-Lay Executive as Chairman
July 03, 2024 09:15 ET
|
Stryve Foods, Inc.
Stryve Foods (Nasdaq: SNAX) Appoints Former Frito-Lay Executive, Kevin Vivian, as Chairman of Board
T-Therapeutics appoints Dr David Hung as Chairman
June 12, 2024 02:23 ET
|
T-Therapeutics
T-Therapeutics appoints Dr David Hung as Chairman Industry veteran, founder of Medivation and serial entrepreneur joins T-Therapeutics to support development of the company’s pipeline of TCR-based...
Autolus Therapeutics Announces Changes to its Board of Directors
April 01, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics Announces Changes to its Board of Directors
General Presidents’ Maintenance Committee for Canada & National Maintenance Council for Canada Appoints Tony Pietrangelo as Chairman of the Board
January 11, 2024 07:30 ET
|
GPMC Canada
KITCHENER, Ontario, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The General Presidents’ Maintenance Committee for Canada and the National Maintenance Council for Canada (GPMC | NMC) is pleased to announce the...